Page last updated: 2024-10-24

carbamazepine and Leukoencephalopathy, Progressive Multifocal

carbamazepine has been researched along with Leukoencephalopathy, Progressive Multifocal in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Leukoencephalopathy, Progressive Multifocal: An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7)

Research Excerpts

ExcerptRelevanceReference
"A patient with epilepsy on carbamazepine developed a rapidly progressive cerebellar syndrome."4.31Progressive multifocal leukoencephalopathy associated with carbamazepine-induced immune dysfunction and recovery after carbamazepine cessation. ( Counsell, CE; Khan, QI; Macleod, AD; Perrott, S, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Perrott, S1
Khan, QI1
Counsell, CE1
Macleod, AD1

Other Studies

1 other study available for carbamazepine and Leukoencephalopathy, Progressive Multifocal

ArticleYear
Progressive multifocal leukoencephalopathy associated with carbamazepine-induced immune dysfunction and recovery after carbamazepine cessation.
    BMJ case reports, 2023, Jul-06, Volume: 16, Issue:7

    Topics: Anticonvulsants; Carbamazepine; Contrast Media; Epilepsy; Gadolinium; Humans; Immune System Diseases

2023